Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00887913 · ClinicalTrials.gov registry record · NA

Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction

A NA study, sponsored by Syneron Medical.

Completed
Registry status
NA
Development phase
69
Enrollment target

NCT00887913: Completed NA study, sponsored by Syneron Medical.

NCT00887913 is a NA study that has completed, run by Syneron Medical. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00887913, a NA study, has completed, sponsored by Syneron Medical.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether the Matrix RF applicator is effective in the treatment of facial skin texture and wrinkle reduction.

Primary Outcome

Improvement of fine lines (wrinkles) assessed per anatomical area treated based on Improvement Scale: 0-4 where higher scores indicate a better outcome. Improvement is graded by means of photographs taken at baseline vs treatment 3 and baseline vs 6week follow up

Interventions

  • DEVICE Fractional RF treatment with Matrix RF applicator

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2008-04
Est. Completion 2009-10
Phase NA
Syneron Medical

18 total trials

What the finished NCT00887913 record still lists

NCT00887913 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Fractional RF treatment with Matrix RF applicator is the first listed.

NCT00887913 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00887913 about?

NCT00887913 is a clinical study titled "Clinical Study to Evaluate the Performance of Fractional Radiofrequency for Improvement of Skin Texture Via Skin Resurfacing and Wrinkles Reduction". The purpose of this study is to determine whether the Matrix RF applicator is effective in the treatment of facial skin texture and wrinkle reduction.

What is the current status of trial NCT00887913?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2008-04. Estimated completion is 2009-10.

What interventions are being tested in trial NCT00887913?

The interventions under investigation include: Fractional RF treatment with Matrix RF applicator (DEVICE).

Who is sponsoring clinical trial NCT00887913?

This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00887913's enrollment target sits among peer trials

69 1133rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00887913, the US trial registry maintained by the National Library of Medicine. NCT00887913 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.